| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.56B | 2.08B | 1.56B | 1.19B | 863.38M | 681.00M |
| Gross Profit | 1.54B | 1.24B | 955.45M | 728.64M | 531.09M | 416.33M |
| EBITDA | 310.92M | 437.03M | 183.37M | 227.62M | -117.11M | 6.28M |
| Net Income | 257.10M | 377.03M | 175.78M | 147.14M | -60.02M | -1.72M |
Balance Sheet | ||||||
| Total Assets | 6.66B | 4.47B | 3.41B | 2.85B | 1.69B | 1.38B |
| Cash, Cash Equivalents and Short-Term Investments | 2.38B | 986.35M | 1.32B | 974.69M | 443.02M | 561.97M |
| Total Debt | 2.10B | 1.40B | 710.66M | 711.11M | 20.44M | 0.00 |
| Total Liabilities | 3.63B | 2.15B | 1.79B | 1.58B | 640.36M | 404.77M |
| Stockholders Equity | 3.03B | 2.33B | 1.61B | 1.27B | 1.05B | 976.25M |
Cash Flow | ||||||
| Free Cash Flow | 145.02M | 329.53M | 128.99M | 179.25M | 74.22M | -34.39M |
| Operating Cash Flow | 244.27M | 408.31M | 189.26M | 235.36M | 124.49M | 38.48M |
| Investing Cash Flow | -940.23M | -490.57M | 12.48M | -830.97M | 252.56M | -356.53M |
| Financing Cash Flow | 1.44B | -45.44M | 41.31M | 598.10M | -174.18M | 299.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $82.35B | 21.21 | 26.15% | 1.55% | -0.14% | 72.35% | |
74 Outperform | $57.94B | 34.98 | 9.13% | 1.61% | 2.83% | 47.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $15.44B | 847.23 | 1.20% | ― | 14.00% | 23.78% | |
58 Neutral | $49.00B | 194.04 | 10.03% | ― | 31.77% | -15.34% | |
49 Neutral | $111.62M | -10.58 | -14.61% | ― | -1.83% | -642.89% | |
42 Neutral | $4.97M | >-0.01 | -233.66% | ― | -9.62% | 95.79% |
On December 18, 2025, Axon Enterprise, Inc. announced that it had delivered a notice of redemption for its 0.50% convertible senior notes due 2027, electing to redeem all outstanding notes on February 10, 2026 at 100% of principal plus accrued and unpaid interest. Holders may convert their notes until the close of business on February 6, 2026, after which conversion will no longer be permitted, with Axon set to settle valid conversions through a mix of cash (for principal and any fractional share amounts) and shares of common stock for any value above principal, based on a 30-trading-day observation period running from December 24, 2025 through February 6, 2026; the move effectively accelerates the wind-down of this debt instrument and could influence Axon’s capital structure and shareholder dilution depending on the level of note conversions.
The most recent analyst rating on (AXON) stock is a Buy with a $713.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.
On December 9, 2025, Axon Enterprise, Inc. entered into agreements with certain holders of its 0.50% convertible senior notes due 2027 to exchange approximately $177.9 million of these notes for cash and common stock. This exchange is expected to close around December 16, 2025, and may influence the market price of Axon’s stock as hedged holders adjust their positions. The company will have about $100.1 million of notes outstanding post-exchange.
The most recent analyst rating on (AXON) stock is a Buy with a $925.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.